01 Growing Adoption of Long-Acting Injectable Treatments for Opioid Use Disorder The substance abuse treatment market is increasingly shifting toward long-acting injectable medications that can reduce the need for daily dosing in opioid use disorder treatment. Monthly formulations can help maintain consistent therapeutic exposure while reducing challenges related to missed doses, medication storage, and daily treatment routines. This approach can also support continuity of care for patients who struggle with adherence to conventional medication schedules. The growing acceptance of extended-duration pharmacotherapy is therefore becoming an important part of substance abuse treatment market trends. In February 2026, Indivior reported that more than 475,000 patients had been treated with SUBLOCADE, its once-monthly injectable treatment for moderate-to-severe opioid use disorder. The company also reported approximately USD 1.2 billion in total revenue for 2025, reflecting the expanding commercial adoption of long-acting addiction treatment.
02 Increasing Integration of Mental Health and Substance Use Treatment Treatment providers are increasingly combining addiction services with mental health care because many individuals seeking substance use treatment also experience depression, anxiety, trauma, or other psychiatric conditions. Treating these conditions through separate programs can fragment care and make recovery more difficult. Integrated models instead coordinate behavioral health assessment, therapy, addiction treatment, and recovery planning within the same care pathway. This transition is broadening the substance abuse treatment industry toward comprehensive programs designed around co-occurring conditions rather than substance use alone. In April 2025, Hazelden Betty Ford Foundation launched an expanded model of care integrating mental health and substance use treatment across all levels of care. The model was implemented across its 15 locations as well as its virtual-care services.
01 Increasing Public Funding for Addiction Treatment and Recovery Services Greater public investment is expanding the financial resources available for addiction treatment, recovery support, crisis intervention, and related behavioral health services. Funding programs can help providers increase treatment capacity, reach underserved populations, and introduce evidence-based services that may otherwise be difficult to finance. Such investment is particularly important for individuals facing both addiction and housing or social instability, where treatment often requires coordinated support beyond medication alone. Continued funding expansion is therefore strengthening substance abuse treatment market demand across community and institutional care settings.
01 Limited Treatment Capacity Restricts Access to Residential Care Insufficient availability of treatment beds can prevent people with substance use disorders from entering structured care when they are ready to begin recovery. Residential and detoxification programs require trained clinicians, suitable facilities, licensing, and continuous patient supervision, making capacity more difficult to expand than standard outpatient services. Long travel distances and limited local availability can further delay treatment. These capacity constraints can restrain substance abuse treatment market growth by leaving part of the potential patient population without timely access to appropriate services.
01 Development of Novel Treatments for Alcohol Use Disorder Alcohol use disorder represents an important opportunity for pharmaceutical developers because existing treatments do not provide satisfactory outcomes for every patient. Companies are investigating new mechanisms that could reduce alcohol consumption, cravings, and relapse while potentially offering faster or more durable therapeutic effects. Successful clinical development would expand the range of pharmacological choices available alongside behavioral interventions. Innovation in alcohol dependence therapy can therefore create new substance abuse treatment market share opportunities for companies developing differentiated medicines.
01 Building a Sustainable Addiction Treatment and Recovery Workforce Treatment expansion depends on sufficient numbers of counselors, behavioral health professionals, peer-support specialists, case managers, and other trained workers. Workforce shortages can limit the number of patients providers are able to serve even when facilities and treatment programs are available. Recovery can also require employment and social reintegration support, increasing the range of professionals needed beyond direct clinical treatment. Developing and retaining this workforce therefore remains a major challenge as substance abuse treatment market size expands.
June 2026 Indivior expanded its addiction treatment portfolio by advancing medication-assisted treatment solutions and digital support programs for substance use disorders. The company focused on improving access to evidence-based therapies and long-term recovery support.
April 2026 Orexo expanded its digital therapeutics and addiction treatment solutions by advancing technology-enabled support platforms for substance use disorder management. The company focused on improving patient engagement and access to recovery resources.
January 2026 Acadia Healthcare expanded its behavioral healthcare network by advancing treatment facilities and specialized care programs for substance use disorders and mental health conditions. The company focused on improving access to comprehensive addiction treatment services.
November 2025 BayMark Health Services expanded its addiction treatment services by strengthening medication-assisted treatment programs and outpatient care capabilities. The company focused on improving accessibility and continuity of care for individuals affected by substance use disorders.